RESUMEN

Existen diversos padecimientos y factores que pueden tener un impacto sobre el funcionamiento cerebral debido a los cambios fisiológicos en estructuras cerebrales. En la práctica clínica, las enfermedades respiratorias, incluyendo el tabaquismo y la enfermedad pulmonar obstructiva crónica (EPOC) no siempre son abordadas desde el ángulo neuropsicológico. Aunadas a otras comorbilidades y a diferentes niveles, el tabaquismo y la EPOC propician una serie de alteraciones fisiológicas causando, a su vez, cambios neuropsicológicos que impactan sobre la calidad de vida y el funcionamiento de los pacientes. Esta revisión resume aspectos críticos relacionados con el funcionamiento cognitivo y las enfermedades respiratorias.

PALABRAS CLAVE

Adicción, EPOC, hipoxia, neuropsicología, tabaquismo.

REFERENCIAS

1. Instituto Nacional de Estadística, Geografía e Informática. A propósito del día del tabaco. México: INEGI, 2008. Fecha de consulta: julio, 2014. Disponible en: www.inegi.org.mx/inegi/contenidos/espanol/prensa/.../tabaco05.pdf.

2. World Health Organization. Tabaquismo. 2011. Fecha de consulta: julio, 2014. Disponible en: http://www.who.int/topics/tobacco/es/

3. Sansores MR, Ramírez-Venegas A. Enfermedad pulmonar obstructiva crónica y la celebración de su primer Día Mundial. Rev Inst Nal Enf Resp Mex 2002; 15(4):199-200.

4. Sansores R, Ramírez-Venegas A, Espinosa M, Sandoval R. Tratamientos para dejar de fumar, disponibles en México. Salud Publica Mex 2002;44 supl 1):S116-S124. http://dx.doi.org/10.1590/S0036-36342002000700017.

5. Secretaría de Salud. Programa de Acción. Adiciones. Tabaquismo. México, 2001. Fecha de consulta: julio, 2014. Disponible en: http://www.salud.gob.mx/unidades/cdi/documentos/tabaquismo.pdf.

6. Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med 2013;369(5):448-457.doi:10.1056/NEJMra1201534.

7. Paul RH, Brickman AM, Cohen RA, et al. Cognitive status of young and older cigarette smokers: data from the international brain database. J Clin Neurosci 2006;13(4):457-465.

8. Jasinska AJ, Zorick T, Brody AL, Stein EA. Dual role of nicotine in addiction and cognition: a review of neuroimaging studies in humans. Neuropharmacology 2014;84:111-122. doi:10.1016/j.neuropharm.2013.02.015.

9. Sansores RH, Ramírez-Venegas A, Hernández-Zenteno R, Mayar-Maya ME, Pérez-Bautista OG, Velázquez Uncal M. Prevalence and diagnosis of chronic obstructive pulmonary disease among smokers at risk. A comparative study of case-finding vs. screening strategies. Respir Med 2013;107(4):580-586. doi: 10.1016/j.rmed.2012.12.010.

10. Guías para el Diagnóstico y Tratamiento de la Enfermedad Pulmonar Obstructiva Crónica. Derivadas del Cuarto Consenso Mexicano para el Diagnóstico y Tratamiento de la EPOC. Neumol Cir Torax 2012;71(1 supl):S8-S89.

11. Benowitz NL. Nicotine addiction. N Engl J Med 2010;362(24):2295-2303. doi: 10.1056/NEJMra0809890.

12. American Psychiatric Association. DSM-IV-TR. Manual diagnóstico y estadístico de los trastornos mentales. Barcelona: Masson; 2002.p.181-199.

13. Volkow ND, Baler RD. Addiction science: Uncovering neurobiological complexity. Neuropharmacology 2014;76 Pt B:235-249. doi: 10.1016/j.neuropharm.2013.05.007

14. Baler RD, Volkow ND. Drug addiction: the neurobiology of disrupted self-control. Trends Mol Med 2006;12(12):559-566. doi:10.1016/j.molmed.2006.10.005.

15. Muñoz MÁ, Sanjuan R, Fernández-Santaella MC, Vila J, Montoya P. Neuropsychological aspects of nicotine craving. Adicciones 2011;23(2):111-123.

16. Volkow ND, Wang GJ, Fowler JS, Tomasi D. Addiction circuitry in the human brain. Annu Rev Pharmacol Toxicol 2012;52:321-336. doi:10.1146/annurevpharmtox-010611-134625.

17. Spronk DB, van Wel JH, Ramaekersc JG, Verkes RJ. Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev 2013;37(8):1838-1859. doi: 10.1016/j.neubiorev.2013.07.003.

18. Zhang X, Salmeron BJ, Ross TJ, et al. Anatomical differences and network characteristics underlying smoking cue reactivity. Neuroimage 2011;54(1):131-141. doi: 10.1016/j.neuroimage.2010.07.063.

19. Durazzo TC, Meyerthoff DJ, Nixon SJ. Chronic cigarette smoking: implications for neurocognition and brain neurobiology. Int J Environ Res Public Health 2010;7(10):3760-3791. doi: 10.3390/ijerph7103760.

20. Rusted JM, Sawyer R, Jones C, Trawley SL, Marchant NL. Positive effects of nicotine on cognition: the deployment of attention for prospective memory. Psychopharmacology (Berl) 2009;202(1-3):93-102.doi:10.1007/s00213-008-1320-7.

21. Mansvelder HD, van Aerde KI, Couey JJ, Brussaard A. Nicotinic modulation of neuronal networks: from receptors to cognition. Psychopharmacology (Berl) 2006;184(3-4):292-305.

22. Ríčný J. Overlooked Alzheimer’s smoking gun? Neurochem Res 2013;38(9): 1774-1776. doi10.1007/s11064-013-1086-0.

23. Almeida OP, Garrido GJ, Alfonso H, et al. 24-month effect of smoking cessation on cognitive function and brain structure in later life. Neuroimage 2011;55(4):1480-1489. doi: 10.1016/j.neuroimage.2011.01.063.

24. Fried PA, Watkinson B, Gray R. Neurocognitive consequences of cigarette smoking in young adults--a comparison with pre-drug performance. Neurotoxicol Teratol 2006;28(4):517-525.

25. Iniciativa Global para la Enfermedad Pulmonar Obstructiva Crónica. Guía para el Diagnóstico, Tratamiento y Prevención de la EPOC. Una Guía para profesionales sanitarios. EUA, 2001.p.6-10. Fecha de consulta: julio, 2014. Disponible en: http://www.fisiorespiracion.es/gold.pdf

26. Mendoza JE, Foundas AL. The vascular system. In: Clinical neuroanatomy: A neurobehavioral approach. New York: Springer;2008.p.520-523.

27. Consenso Mexicano de EPOC. Intervenciones prioritarias. Neumol Cir Torax 2007;66(sup 2):S26-S31.

28. Areza-Fegyveres R, Kairalla RA, Carvalho CR, Nitrini R. Cognition and chronic hypoxia in pulmonary diseases. Dement Neuropsychol 2010;4(1):14-22.

29. Torre-Bouscoulet T, Vázquez-García JC, Pérez-Padilla R. Oxigenoterapia crónica domiciliaria en altitudes moderadas. Un enorme reto en salud. Neumol Cir Torax 2011;70(3):149-151.

30. Vargas-Domínguez C, Gochicoa-Rangel L, Velázquez-Uncal M, et al. Pruebas de función respiratoria, ¿cuál y a quién? Neumol Cir Torax 2011;70(2):101-117.

31. Dodd JW, Getov SV, Jones PW. Cognitive function in COPD. Eur Respir J 2010;35(4):913-922. doi: 10.1183/09031936.00125109.

32. Kuwaki, T. Hypothalamic modulation of breathing. Adv Exp Med Biol 2010;669:243-247. doi: 10.1007/978-1-4419-5692-7_49.

33. Patel AJ, Honoré E. Molecular physiology of oxygen-sensitive potassium channels. Eur Respir J 2001;18(1):221-227.

34. Virués-Ortega J, Garrido E, Javierre C, Rivero PD. Funcionamiento neuropsicológico bajo condiciones de hipoxia aguda y crónica asociada a la altitud. Arch Biol Andina 2008;14(1):40-50.

35. Kawasaki K, Traynelis SF, Dingledine R. Different responses of CA1 and CA3 regions to hypoxia in rat hippocampal slice. Neurophysiol 1990;63(3):385-394.

36. Di Paola M, Caltagirone C, Fadda L, Sabatini U, Serra L, Carlesimo GA. Hippocampal atrophy is the critical brain change in patients with hypoxic amnesia. Hippocampus 2008;18(7):719-728. doi: 10.1002/hipo.20432.

37. Hopkins RO, Bigler, ED. Hypoxic and anoxic conditions of the CNS. In: Morgan J, Ricker J, editors. Textbook of clinical neuropsychology. New York, EUA: Taylor & Francis; 2008.p.521-535.

38. Shim TS, Lee JH, Kim SY, et al. Cerebral metabolic abnormalities in COPD patients detected by localized proton magnetic resonance spectroscopy. Chest 2001;120(5):1506-1513.

39. Morgan B. Vascular consequences of intermittent hypoxia. In: Roach RC, Wagner PD, Hackett PH, editors. Hypoxia and the circulation. Advances in experimental medicine and biology. New York, EUA: Springer; 2007.p.51-67.

40. Singh B, Parsaik AK, Mielke MM, et al. Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging. Mayo Clinic Pro 2013;88(11):1222-1230. doi: 10.1016/j.mayocp.2013.08.012.

41. Tulek B, Atalay NB, Yildirim G, Kanat F, Süerdem M. Cognitive function in chronic obstructive pulmonary disease: relationship to global initiative for chronic obstructive lung disease 2011 categories. Respirology 2014;19(6):873-880.doi: 10.1111/resp.12333.

42. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189-198.

43. Ardila A, Ostrosky F. Guía para el diagnóstico neuropsicológico. 2012,127-152. Fecha de consulta: julio, 2014. Disponible en: http://www.ineuro.cucba.udg.mx/libros/bv_guia_para_el_diagnostico_neuropsicologico.pdf.

44. Lezak M. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004.p.714.

45. Kozora E, Emery CF, Ellison MC, Wamboldt FS, Díaz PT, Make P. Improved neurobehavioral functioning in emphysema patients following lung volume reduction surgery compared with medical therapy. Chest 2005;128(4):2653-2663.

46. Kozora E, Emery CF, Zhang L, Hoth KF, Murphy J, Make B; National Emphysema Treatment Trial Research Group. Sequential cognitive skills in emphysema patients following lung volume reduction surgery: a 2-year longitudinal study. J Cardiopulm Rehabil Prev 2011;31(6):386-391. doi: 10.1097/HCR.0b013e3182343bc8.

47. Dal Negro RW, Bonadiman L, Tognella S, Bricolo FP, Turco P. Extent and prevalence of cognitive dysfunction
in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values. Int J Chron Obstruct Pulmon Dis 2014;9:675-683. doi: 10.2147/COPD.S63485.

48. Ortapamuk H, Naldoken S. Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairment. Ann Nucl Med 2006;20(2):99-106.

49. Crews WD, Jefferson AL, Bolduc T, et al. Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol 2001;16(7):643-652.

50. Borson S, Scanlan J, Friedman S, et al. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis 2008;3(3):429-434.

51. Kent BD, Mitchell PD, McNicholas WT. Hypoxemia in patients with COPD: causes, effects, and disease progression. Int J Chron Obstruct Pulmon Dis 2011;6:199-208. doi: 10.2147/COPD.S10611.

52. Tombaugh TN. Trail Making Test A and B: Normative data stratified by age and education. Arch Clin Neuropsychol 2004;19(2):203-214.

53. Tombaugh TN, Kazak J, Rees L. Normative data stratified by age and education for two measures of verbal fluency: FAS and animal naming. Arch Clin Neuropsychol 1999;14(2):167-177.

54. Liesker JJ, Postma DS, Beukema RJ, et al. Cognitive performance in patients with COPD. Respir Med 2004;98(4):351-356.

55. De Carolis A, Giubilei F, Caselli G, et al. Chronic obstructive pulmonary disease is associated with altered neuropsychological performance in young adults. Dement Geriatr Cogn Dis Extra 2011;1(1):402-408. doi: 10.1159/000333079.

56. Grant I, Heaton RK, McSweeney AJ, Adams KM, Timms RM. Brain dysfunction in COPD. Chest 1980;77(2 Suppl):S308-S309.

57. Dodd JW, Chung AW, van den Broek MD, Barrick TR, Charlton RA, Jones PW. Brain structure and function in chronic obstructive pulmonary disease: a multimodal cranial magnetic resonance imaging study. Am J Respir Crit Care Med 2012;186(3):240-245. doi:10.1164/rccm.201202-0355OC.

58. Kaptein AA, Scharloo M, Fischer MJ, et al. 50 years of psychological research on patients with COPD- road to ruin or highway to heaven? Respir Med 2009;103(1):3-11. doi: 10.1016/j.rmed.2008.08.019.

59. Warrington JP, Ashpole N, Csiszar A, Lee YW, Ungvari Z, Sonntag WE. Whole brain radiation-induced vascular cognitive impairment: mechanisms and implications. J Vasc Res 2013;50(6):445-457.doi:10.1159/000354227.

60. Schega L, Peter B, Törpel A, Mutschler H, Isermann B, Hamacher D. Effects of intermittent hypoxia on cognitive performance and quality of life in elderly adults: a pilot study. Gerontology 2013;59(4):316-323.doi:10.1159/000350927.

61. Portellano JA. Introducción a la neuropsicología. Madrid: McGrawHill; 2005.p.233-239.

62. Emery CF, Green MR, Suh S. Neuropsychiatric function in chronic lung disease: the role of pulmonary rehabilitation. Respir Care 2008;53(9):1208-1216.

63. Etnier J, Johnston R, Dagenbach D, Pollard RJ, Rejeski WJ, Berry M. The relationship among pulmonary function, aerobic fitness, and cognitive functioning in older COPD. Chest 1999;116(4):953-960.

64. Antonelli-Incalzi R, Corsonello A, Pedone C. Drawing impairment predicts mortality in severe COPD. Chest 2006;130(6):1687-1694.

65. Sakurai Y, Kanazawa I. Acute effects of cigarettes in non-deprived smokers on memory, calculation and executive functions. Hum Psychopharmacol 2002; 17(7):369-373.doi:10.1002/hup.424.

66. Yakir A, Rigbi A, Kanyas K, et al. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur Neuropsychopharmacol 2007;17(5):339-351.

67. Dodd JW, Charlton RA, van den Broek MD, Jones PW. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest 2013;144(1):119-127. doi:10.1378/chest.12-2099.

68. Li J, Huang Y, Fei GH. The evaluation of cognitive impairment and relevant factors in patients with chronic obstructive pulmonary disease. Respiration 2013;85(2):98-105.doi:10.1159/000342970.

69. Chang SS, Chen S, McAvay GJ, Tinetti ME. Effect of coexisting chronic obstructive pulmonary disease and cognitive impairment on health outcomes in older adults. J Am Geriatr Soc 2012;60(10):1839-1846.doi:10.1111/j.1532-5415.2012.04171.

70. Pereira ED, Viana CS, Taunay TC, Sales PU, Lima JW, Holanda MA. Improvement of cognitive function after a three-month pulmonary rehabilitation program for COPD patients. Lung 2011;189(4):279-285.doi:10.1007/s00408-011-9303-6.